These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19933084)

  • 1. Re: Lymphopenia associated with adjuvant anthracycline/taxane regimens.
    Cadoo K; Lowery M; McCaffrey J
    Clin Breast Cancer; 2009 Nov; 9(4):262. PubMed ID: 19933084
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of anthracycline and taxane therapy-induced symptoms for the patients with breast cancer].
    Fukada I; Ito Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():548-52. PubMed ID: 25831820
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients.
    Zelek L; Cottu P; Tubiana-Hulin M; Vannetzel JM; Chollet P; Misset JL; Chouaki N; Marty M; Gamelin E; Culine S; Dieras V; Mackenzie S; Spielmann M
    J Clin Oncol; 2002 May; 20(10):2551-8. PubMed ID: 12011135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute typhlitis associated with taxane-based chemotherapy].
    Gagliano E; Tonante A; Taranto F; Mamo M; Sturniolo G; Colonese F; Sturniolo G
    G Chir; 2010; 31(11-12):514-7. PubMed ID: 21232195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible mechanisms behind taxane-anthracycline sequencing.
    Sahin I; Ararat E; Altundag K
    Lancet Oncol; 2010 Jun; 11(6):514-5. PubMed ID: 20522380
    [No Abstract]   [Full Text] [Related]  

  • 6. Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane.
    Okanami Y; Ito Y; Watanabe C; Iijima K; Iwase T; Tokudome N; Takahashi S; Hatake K
    Breast Cancer; 2011 Jul; 18(3):182-8. PubMed ID: 21394515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taxane-based regimens as a risk factor for chemotherapy-induced amenorrhea.
    Najafi S; Djavid GE; Mehrdad N; Rajaii E; Alavi N; Olfatbakhsh A; Najafi M; Bahrami A; Heidari K
    Menopause; 2011 Feb; 18(2):208-12. PubMed ID: 21037487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body Composition, Adherence to Anthracycline and Taxane-Based Chemotherapy, and Survival After Nonmetastatic Breast Cancer.
    Cespedes Feliciano EM; Chen WY; Lee V; Albers KB; Prado CM; Alexeeff S; Xiao J; Shachar SS; Caan BJ
    JAMA Oncol; 2020 Feb; 6(2):264-270. PubMed ID: 31804676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [High-risk situation - which is the best chemotherapy?].
    von Minckwitz G
    Gynakol Geburtshilfliche Rundsch; 2008; 48(3):118-29. PubMed ID: 18566528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy.
    Li M; Ma F; Wang J; Li Q; Zhang P; Yuan P; Luo Y; Cai R; Fan Y; Chen S; Li Q; Xu B
    Chin J Cancer; 2018 Jan; 37(1):4. PubMed ID: 29382381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent perspectives second-line chemotherapy for breast cancer].
    Fujiuchi N; Ohokubo K; Saeki T; Sasaki Y
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):11-4. PubMed ID: 15675574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk profile of patients with HER2/neu-positive breast cancer treated with anthracycline-taxane-containing adjuvant chemotherapy and/or trastuzumab.
    Jones LW; Haykowsky M; Peddle CJ; Joy AA; Pituskin EN; Tkachuk LM; Courneya KS; Slamon DJ; Mackey JR
    Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1026-31. PubMed ID: 17507633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged disease control in a patient with anthracycline- and taxane-resistant breast cancer.
    Castaneda CA; Gómez HL
    Clin Breast Cancer; 2009 Nov; 9(4):E1-3. PubMed ID: 19933071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
    Rugo HS; Klein P; Melin SA; Hurvitz SA; Melisko ME; Moore A; Park G; Mitchel J; Bågeman E; D'Agostino RB; Ver Hoeve ES; Esserman L; Cigler T
    JAMA; 2017 Feb; 317(6):606-614. PubMed ID: 28196257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Autologous Breast Reconstruction Complications by Type of Neoadjuvant Chemotherapy Regimen.
    Olawoyin OM; Mehta S; Chouairi F; Gabrick KS; Avraham T; Pusztai L; Alperovich M
    Plast Reconstr Surg; 2021 Dec; 148(6):1186-1196. PubMed ID: 34644277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane.
    Fornier MN; Modi S; Panageas KS; Norton L; Hudis C
    Cancer; 2005 Oct; 104(8):1575-9. PubMed ID: 16134178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of anthracyclines in the treatment of early breast cancer.
    Gianni L; Norton L; Wolmark N; Suter TM; Bonadonna G; Hortobagyi GN
    J Clin Oncol; 2009 Oct; 27(28):4798-808. PubMed ID: 19687331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the sequence of taxane administration affect the outcome of patients with breast cancer in the adjuvant and neoadjuvant settings?
    Alkan A; Sahin U; Altundag K
    Med Oncol; 2010 Dec; 27(4):1430. PubMed ID: 19876779
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 2 study of single-agent IV vinflunine as third-line treatment of metastatic breast cancer after failure of anthracycline-/taxane-based chemotherapy.
    Fumoleau P; Cortés-Funes H; Taleb AB; Chan S; Campone M; Pouget JC; Tubiana-Hulin M; Slabber CF; Caroff-Paraïso I; Alberts AS; Ben Ayed F
    Am J Clin Oncol; 2009 Aug; 32(4):375-80. PubMed ID: 19487917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversibility of Left Ventricle Longitudinal Strain Alterations Induced by Adjuvant Therapy in Early Breast Cancer Patients.
    Mele D; Malagutti P; Indelli M; Ferrari L; Casadei F; Da Ros L; Pollina A; Fiorencis A; Frassoldati A; Ferrari R
    Ultrasound Med Biol; 2016 Jan; 42(1):125-32. PubMed ID: 26603736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.